8-K

NATIONAL HEALTHCARE CORP (NHC)

8-K 2022-11-04 For: 2022-11-03
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 4, 2022 (November 3, 2022)

NATIONAL HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-13489 52-2057472
(State or other jurisdiction of<br><br> <br>incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
100 E. Vine Street<br><br> <br>Murfreesboro, Tennessee 37130
(Address of Principal Executive<br><br> <br>Offices) (Zip Code)

Registrants telephone number, including area code: (615) 890-2020

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
--- ---
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class Trading Symbol(s) Name of each exchange on which<br><br> <br>registered
Common Stock, $.01 par value NHC NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐


ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

National HealthCare Corporation (“NHC”) issued a press release on November 3, 2022, announcing its September 30, 2022 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.

ITEM 8.01. OTHER EVENTS.

NHC issued a press release on November 4, 2022, announcing its quarterly common dividend. The entire press release is attached as Exhibit 99.2 and is incorporated by reference herein.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d)         Exhibits.

Exhibit No. Description of Exhibit
99.1 Copy of press release issued on November 3, 2022, by National HealthCare Corporation announcing September 30, 2022 earnings.
99.2 Copy of press release issued on November 4, 2022 by National HealthCare Corporation announcing quarterly common dividend.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:         November 4, 2022

NATIONAL HEALTHCARE CORPORATION
By: /s/ Brian F. Kidd
Name: Brian F. Kidd
Title: Senior VP/Controller<br><br> <br>Principal Accounting Officer

ex_442460.htm

Exhibit 99.1

pic1.jpg

For release: November 3, 2022

Contact: Brian F. Kidd, SVP/Controller

Phone: (615) 890-2020

NHC Reports Third Quarter 2022 Earnings

MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and government stimulus income for the quarter ended September 30, 2022 totaled $270,843,000 compared to $276,737,000 for the quarter ended September 30, 2021, a decrease of 2.1%. The net operating revenues decrease during the third quarter of 2022 was primarily driven by the reduction in government stimulus income of $10.4 million during the third quarter of 2022 compared to the same period a year ago, as well as us exiting the seven skilled nursing facilities in Massachusetts and New Hampshire during the third quarter of 2022. Excluding the government stimulus income, same-facility net operating revenues increased 3.8% during the third quarter of 2022 compared to the same period a year ago.

For the quarter ended September 30, 2022, the reported GAAP net loss attributable to NHC was $2,429,000 compared to a net loss of $3,348,000 for the same period in 2021. Excluding the unrealized losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended September 30, 2022 was $7,783,000 compared to $14,884,000 for the same period in 2021 ^(*)^. The decrease in non-GAAP earnings for the third quarter of 2022 compared to the same period in 2021 was primarily due to the $10.4 million less of government stimulus income recorded, as well as incurring inflationary wage pressures on our labor costs. GAAP diluted loss per share was $0.16 for the quarter ended September 30, 2022 compared to a diluted loss per share of $0.22 for the same period in 2021. Adjusted diluted earnings per share were $0.50 and $0.96 for the quarters ended September 30, 2022 and 2021, respectively ^(*)^.

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,726 beds. NHC affiliates also operate 23 assisted living communities with 1,181 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 29 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q and 10-K, and include, among others, the following: liabilities and other claims asserted against us and patient care liabilities, as well as the resolution of current litigation; availability of insurance and assets for indemnification; national and local economic conditions; including their effect on the availability and cost of labor, utilities and materials; the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries; and other factors referenced or incorporated by reference in the S.E.C. filings. The risks included here are not exhaustive. All forward-looking statements represent NHC’s best judgment as of the date of this release.

-more-


Page 2

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

Three Months Ended Nine Months Ended
September 30 September 30
2022 2021 2022 2021
(unaudited) (unaudited)
Revenues and grant income:
Net patient revenues $ 260,247 $ 254,817 $ 776,661 $ 708,648
Other revenues **** 10,596 11,491 **** 33,584 33,916
Government stimulus income **** - 10,429 **** 10,940 48,304
Net operating revenues and grant income **** 270,843 276,737 **** 821,185 790,868
Costs and expenses:
Salaries, wages and benefits **** 173,198 170,235 **** 518,828 483,263
Other operating **** 72,883 73,109 **** 218,279 204,211
Facility rent **** 10,294 10,204 **** 30,770 30,437
Depreciation and amortization **** 10,253 10,229 **** 30,011 30,521
Interest **** 137 198 **** 451 657
Total costs and expenses **** 266,765 263,975 **** 798,339 749,089
Income from operations **** 4,078 12,762 **** 22,846 41,779
Non-operating income **** 2,731 3,399 **** 8,451 15,245
Gain on acquisition of equity method investment **** - - **** - 95,202
Unrealized losses on marketable equity securities **** (11,056 ) (23,797 ) **** (11,479 ) (23,227 )
Income/(loss) before income taxes **** (4,247 ) (7,636 ) **** 19,818 128,999
Income tax (provision)/benefit **** 1,140 4,090 **** (5,415 ) (5,907 )
Net income/(loss) **** (3,107 ) (3,546 ) **** 14,403 123,092
Net (income)/loss attributable to noncontrolling interest **** 678 198 **** 1,689 (290 )
Net income/(loss) attributable to National HealthCare Corporation $ (2,429 ) $ (3,348 ) $ 16,092 $ 122,802
Net income/(loss) per common share
Basic $ (0.16 ) $ (0.22 ) $ 1.04 $ 8.00
Diluted $ (0.16 ) $ (0.22 ) $ 1.04 $ 7.97
Weighted average common shares outstanding
Basic **** 15,445,569 15,364,043 **** 15,438,375 15,347,042
Diluted **** 15,445,569 15,364,043 **** 14,577,103 15,414,683
Dividends declared per common share $ 0.57 $ 0.52 $ 1.69 $ 1.56

Balance Sheet Data

Sept. 30 Dec. 31
(in thousands) 2022 2021
(unaudited)
Cash, cash equivalents and marketable securities $ 176,729 $ 256,025
Restricted cash, cash equivalents and marketable securities **** 171,898 175,884
Current assets **** 344,529 426,638
Property and equipment, net **** 511,373 520,996
Total assets **** 1,295,559 1,403,396
Current liabilities **** 210,156 263,201
NHC stockholders' equity **** 877,311 903,004

-more-


Page 3

Selected Operating Statistics

Three Months Ended Nine Months Ended
September 30 September 30
2022 2021 2022 2021
(unaudited) (unaudited)
Skilled Nursing Per Diems: **** **** **** **** **** **** **** ****
Medicare $ 535.60 $ 523.98 $ 540.30 $ 528.60
Managed Care **** 429.22 404.43 **** 425.39 406.32
Medicaid **** 237.61 231.39 **** 230.79 225.68
Private Pay and Other **** 265.68 257.13 **** 268.13 254.03
Average Skilled Nursing Per Diem $ 302.43 $ 295.40 $ 301.91 $ 297.04
Skilled Nursing Patient Days: **** **** **** **** **** **** **** ****
Medicare **** 81,940 87,534 **** 258,961 271,024
Managed Care **** 52,956 57,486 **** 163,823 183,593
Medicaid **** 302,500 315,979 **** 919,931 895,955
Private Pay and Other **** 169,068 158,011 **** 489,477 439,225
Total Skilled Nursing Patient Days **** 606,464 619,010 **** 1,832,192 1,789,797

The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

Three Months Ended Nine Months Ended
September 30 September 30
2022 2021 2022 2021
(unaudited) (unaudited)
Net income/(loss) attributable to National Healthcare Corporation $ (2,429 ) $ (3,348 ) $ 16,092 $ 122,802
Non-GAAP adjustments
Unrealized losses on marketable equity securities **** 11,056 23,797 **** 11,479 23,227
Operating results for newly opened facilities not at full capacity^(1)^ **** 2,105 115 **** 4,033 480
Gain on acquisition of equity method investment **** - - **** - (95,202 )
Stock-based compensation expense **** 639 726 **** 1,980 1,905
Income tax benefit on non-GAAP adjustments **** (3,588 ) (6,406 ) **** (4,548 ) (6,369 )
Non-GAAP Net income $ 7,783 $ 14,884 $ 29,036 $ 46,843
GAAP diluted earnings/(loss) per share $ (0.16 ) $ (0.22 ) $ 1.04 $ 7.97
Non-GAAP adjustments
Unrealized losses on marketable equity securities **** 0.53 1.14 **** 0.56 1.12
Operating results for newly opened facilities not at full capacity ^(1)^ **** 0.10 0.01 **** 0.19 0.02
Gain on acquisition of equity method investment **** - - **** - (6.16 )
Stock-based compensation expense **** 0.03 0.03 **** 0.09 0.09
Non-GAAP diluted earnings per share $ 0.50 $ 0.96 $ 1.88 $ 3.04

^(1)^ The newly opened facilities not at full capacity for the 2022 period presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency. The newly opened facilities for the 2021 period presented consisted of operations opened from 2019 through 2021. The 2021 period consisted of one memory care facility.

ex_442466.htm

Exhibit 99.2

pic1.jpg

For release: November 4, 2022

Contact: Brian F. Kidd, SVP/Controller

Phone: (615) 890-2020

NHC Announces Common Dividend

MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 57 cents per common share to shareholders of record on December 30, 2022 and payable on February 1, 2023.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q and 10-K, and include, among others, the following: liabilities and other claims asserted against us and patient care liabilities, as well as the resolution of current litigation; availability of insurance and assets for indemnification; national and local economic conditions; including their effect on the availability and cost of labor, utilities and materials; the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries, the ability of third parties for whom we have guaranteed debt to refinance certain short term debt obligations; and other factors referenced or incorporated by reference in the S.E.C. filings. The risks included here are not exhaustive. All forward-looking statements represent NHC’s best judgment as of the date of this release.

About NHC

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,726 beds. NHC affiliates also operate 23 assisted living communities with 1,181 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 29 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.